Your session is about to expire
← Back to Search
Auricular Point Acupressure for Alzheimer's Disease
Study Summary
This trial will examine if pain relief, pain sensory change, and immune biomarkers change after auricular point acupressure in patients with Alzheimer's disease and related disorders.
- Alzheimer's Disease
- Pain
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many individuals are actively engaged in this research endeavor?
"Affirmative. According to the clinicaltrials.gov database, this experimental trial is presently recruiting participants; it was launched on August 1st 2018 and modified most recently on June 14th 2022. A total of 40 patients are required for this investigation at a single facility."
Does this experiment still entertain applicants?
"Indeed, clinicaltrials.gov lists this medical trial as currently recruiting patients. The study was initially posted on August 1st 2018 and the most recent update to its information occurred June 14th 2022. It is in need of 40 participants from a single site."
Can individuals aged over 40 years enroll in this medical trial?
"This trial only accepts patients between 21 and 85 years of age. By contrast, 94 studies focus on individuals younger than 18 while 785 are geared towards those who are over 65."
Are there any eligibility criteria for participating in this clinical trial?
"This clinical trial is seeking 40 individuals with chronic pain ranging from 21 to 85 years old. Requirements for potential study members include having a caretaker that can facilitate APA, an average intensity of pain greater than 4 in the last week according to the 10 point numerical scale, being patients at either JHMATC or JHADRC facilities, committing 5 weeks of visits (firstly office and later home based) as well as two follow-up home visits 3 and 6 months after commencement date respectively; moreover, participants must be diagnosed with any type of dementia between mild and moderate stages (MoCA score ≥ 8), have endured their condition"
Share this study with friends
Copy Link
Messenger